REGIONAL EXPERIENCE WITH DURVALUMAB IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER AFTER RADICAL CHEMORADIOTHERAPY

A.V. Sultanbaev1, A.A. Izmaylov1, O.N. Lipatov2, A.F. Nasretdinov1, K.V. Menshikov1,2, N.I. Sultanbayeva1, Sh.I. Musin1, G.A. Serebrennikov2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa Sultanbaev Aleksandr V. ― Cand. of Sci. (Med.), Head of the Department of antitumor drug Therapy of the Republican Clinical Oncology Dispensary 73/1 Oktyabrya Ave., Ufa, 450054, Russian Federation, … Читать далее

ACUTE HEMATOLOGICAL TOXICITY OF RADIOTHERAPY FOR CERVICAL CANCER BY USE OF POLYRADIOSENSITIZATION WITH CISPLATIN AND GEMCITABINE ― TRIAL RESULTS OF AZERBAIJAN NATIONAL CENTER OF ONCOLOGY

K.S. Akperov National Center of Oncology, Baku, The Republic of Azerbaijan Akperov K.S. ― radiation oncologist, researcher at the department of radiation therapy of National Center of Oncology 79B G. Zardabi Str., Baku, The Republic of Azerbaijan, AZ1012, e-mail: akperovkamal@yahoo.com  Abstract The aim of this research was study of acute toxicity of chemoradiotherapy for locally … Читать далее